SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-000891
Filing Date
2022-07-26
Accepted
2022-07-26 10:46:03
Documents
13
Period of Report
2022-07-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbgl_8k.htm   iXBRL 8-K 26896
2 EXHIBIT 17.1 ex17x1.htm EX-17.1 6325
  Complete submission text file 0001079973-22-000891.txt   207928

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cbgl-20220721.xsd EX-101.SCH 2986
4 XBRL LABEL FILE cbgl-20220721_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cbgl-20220721_pre.xml EX-101.PRE 22377
7 EXTRACTED XBRL INSTANCE DOCUMENT cbgl_8k_htm.xml XML 3579
Mailing Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071
Business Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071 (310) 986-4929
CANNABIS GLOBAL, INC. (Filer) CIK: 0001413488 (see all company filings)

IRS No.: 831754057 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-56141 | Film No.: 221105305
SIC: 2836 Biological Products, (No Diagnostic Substances)